Revvity is a science-based solutions company headquartered in Waltham, Massachusetts. It provides reagents, consumables, assays, instruments, and software for the life sciences and diagnostics sectors. The company's work spans the translational research pipeline, from discovery through development, and from diagnosis to treatment.
With a global workforce of over 11,000 employees, Revvity generates annual revenue exceeding $2.9 billion and serves customers in more than 190 countries. It is listed on the S&P 500 index. Its technical domains include life sciences, diagnostics, automation, multi-omics, and its Signals software business.
The company's products are used across several key verticals, including pharmaceutical and biotech firms, diagnostic laboratories, academic institutions, and government agencies.
